Skip to content

Imaging Evaluation of Fundus Structural Changes Following Posterior Scleral Reinforcement in High Myopia

Clinical Efficacy and Fundus Imaging Evaluation of Posterior Scleral Reinforcement in High Myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121932
Enrollment
Unknown
Registered
2026-04-07
Start date
2026-07-24
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Posterior scleral reinforcement (PSR) group:undergoing (PSR) surgery
control group:none

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 8 and 60 years, regardless of gender; 2. Diagnosed with high myopia without significant myopic traction maculopathy. The specific criteria are as follows: For children aged 8 to 12 years (inclusive): Spherical equivalent (SE) = 25.5 mm; For adolescents aged 12 to 18 years: SE = 26.0 mm; For adults aged 18 years and older: SE = 26.5 mm; 3. (For the PSR group) Have completed a preoperative evaluation by the attending physician and have definitively decided to undergo PSR surgery; (For the control group) Have been assessed by the attending physician as currently having no indication for PSR surgery and have explicitly chosen and committed to conventional non-surgical refractive correction options (e.g., spectacles or contact lenses); 4. Have no history of prior ocular surgery or trauma.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe opacity of the refractive media; 2. Individuals with pre-existing severe vitreomacular traction syndrome or myopic traction maculopathy caused by a severe epiretinal membrane; 3. Individuals with active ocular infections or inflammatory diseases; 4. Individuals with severe ocular disorders, such as keratoconus, glaucoma, or severe dry eye; 5. Individuals with systemic diseases, such as diabetes mellitus, connective tissue disorders, or autoimmune diseases; 6. Individuals with poor cooperation, making them unable to comply with the examinations and surgery.

Design outcomes

Primary

MeasureTime frame
axial length;

Secondary

MeasureTime frame
Ocular fundus structural and blood flow parameters;

Countries

China

Contacts

Public ContactShao Yilei

Eye Hospital, Wenzhou Medical University

shaoyl1986@wmu.edu.cn+86 13676736350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026